A sham case-control study of effectiveness of DTP-Hib-hepatitis B vaccine against rotavirus acute gastroenteritis in Kenya

Table 3 Table comparing immunization status among rotavirus AGE cases and controls, western Kenya, 2010–11

Variable^a	Cases (N = 91)	Community controls (N = 271)	Hospital Non-AGE controls (N = 203)	Hospital AGE controls unmatched (N = 252)
	n (%)	n (%)	n (%)	n (%)
Number of pentavalent doses received^b
0 doses	1 (1)	3 (1)	0 (0)	3 (2)
1 dose	4 (5)	5 (2)	7 (5)	7 (4)
2 doses	12 (16)	25 (10)	20 (14)	23 (12)
3 doses	58 (77)	210 (86)	118 (81)	160 (83)
Of those with 2 doses of pentavalent^c
Dose 2 received on time	47 (67)	152 (65)	89 (64)	121 (66)
Dose 2 not received on time	23 (33)	83 (35)	49 (36)	61 (34)
Of those with 3 doses of pentavalent^c
Dose 3 received on time	30 (52)	117 (56)	61 (52)	90 (56)
Dose 3 not received on time	28 (48)	93 (44)	57 (48)	70 (44)

^aFirst response to each variable was referent category in conditional logistic regression.
^bA dose was considered given if it was given at least 14 days before the date of admission of the cases for cases and matched controls while for the unmatched controls it was 14 days before their date of admission. Timely vaccination considered vaccination <1 before or >2 weeks after scheduled date of pentavalent2 pentavalent3 at 10 weeks and 14 weeks of age respectively.
^cUnknown/missing responses not included.

ISSN: 1471-2334